Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

MDXG

Mimedx Group Inc

Dec 01 • 04:00PM ET

7.99

Dollar change +0.22
Percentage change 2.83	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.02	Insider Own	5.00%	Shs Outstand	113.71M	Perf Week	4.31%
Market Cap	929.88M	Forward P/E	24.81	EPS next Y	0.32	Insider Trans	0.09%	Shs Float	110.56M	Perf Month	23.88%
Income	-2.54M	PEG	-	EPS next Q	0.07	Inst Own	55.26%	Short Float / Ratio	3.72% / 6.48	Perf Quarter	4.04%
Sales	309.02M	P/S	3.01	EPS this Y	131.52%	Inst Trans	4.11%	Short Interest	4.11M	Perf Half Y	38.24%
Book/sh	0.01	P/B	699.04	EPS next Y	209.62%	ROA	2.40%	Target Price	11.65	Perf Year	145.85%
Cash/sh	0.70	P/C	11.46	EPS next 5Y	15.00%	ROE	5.20%	52W Range	2.43 - 8.60	Perf YTD	187.41%
Dividend	-	P/FCF	107.25	EPS past 5Y	-	ROI	-1.78%	52W High	-7.09%	Beta	1.66
Dividend %	-	Quick Ratio	3.10	Sales past 5Y	-2.83%	Gross Margin	81.91%	52W Low	228.81%	ATR	0.34
Employees	867	Current Ratio	3.54	Sales Q/Q	20.72%	Oper. Margin	4.77%	RSI (14)	68.99	Volatility	4.10% 5.23%
Optionable	Yes	Debt/Eq	0.52	EPS Q/Q	163.71%	Profit Margin	-0.82%	Rel Volume	0.99	Prev Close	7.77
Shortable	Yes	LT Debt/Eq	0.52	Earnings	Oct 30 AMC	Payout	-	Avg Volume	634.87K	Price	7.99
Recom	1.00	SMA20	15.45%	SMA50	16.01%	SMA200	32.73%	Volume	626,840	Change	2.83%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-27-23	Initiated	Craig Hallum	Buy	$12
Oct-13-22	Initiated	Mizuho	Buy	$7
Jul-26-21	Initiated	Northland Capital	Outperform	$23
Mar-19-21	Initiated	H.C. Wainwright	Buy	$20

Nov-13-23 08:00AM	MIMEDX to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-02-23 08:00AM	MIMEDX to Highlight Published Data at SAWC Fall (GlobeNewswire)
Oct-31-23 09:09AM	MiMedx Group, Inc. (NASDAQ:MDXG) Q3 2023 Earnings Call Transcript (Insider Monkey)
07:28AM	Q3 2023 MiMedx Group Inc Earnings Call (Thomson Reuters StreetEvents)
06:50AM	MDXG: Xenografts and Synthetics Options for Expansion (Zacks)
06:03PM	Loading…
Oct-30-23 06:03PM	MiMedx Group Inc (MDXG) Reports 20.7% Increase in Q3 2023 Net Sales (GuruFocus.com)
04:50PM	MiMedx: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	MIMEDX Announces Third Quarter 2023 Operating and Financial Results (GlobeNewswire)
Oct-27-23 10:01AM	Roblox upgraded, Bristol Myers downgraded: Wall Street's top analyst calls (The Fly)
Oct-16-23 08:00AM	MIMEDX to Host Third Quarter 2023 Operating and Financial Results Conference Call on October 30 (GlobeNewswire)
Sep-26-23 08:00AM	MIMEDX Announces Launch of EPIEFFECT (GlobeNewswire)
Sep-05-23 08:00AM	MIMEDX to Present at Upcoming Investor Conferences (GlobeNewswire)
Aug-15-23 04:01PM	MediWound Announces Collaboration with MIMEDX on EscharEx® Phase III Study (GlobeNewswire)
Aug-08-23 02:05PM	Institutional owners may ignore MiMedx Group, Inc.'s (NASDAQ:MDXG) recent US$68m market cap decline as longer-term profits stay in the green (Simply Wall St.)
Aug-02-23 08:53AM	Q2 2023 MiMedx Group Inc Earnings Call (Thomson Reuters StreetEvents)
06:36AM	Loading…
06:36AM	MDXG: Beat and a Raise (Zacks)
Aug-01-23 04:07PM	MiMedx: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	MIMEDX Announces Second Quarter 2023 Operating and Financial Results (GlobeNewswire)
Jul-26-23 01:30PM	Northland Capital Markets Institutional Investor Conference (ACCESSWIRE)
Jul-18-23 08:00AM	MIMEDX to Host Second Quarter 2023 Operating and Financial Results Conference Call on August 1 (GlobeNewswire)
Jul-11-23 08:30AM	MIMEDX Announces Favorable Ruling in Putative Securities Class Action Case (GlobeNewswire)
Jul-05-23 08:00AM	MIMEDX Appoints Doug Rice as Chief Financial Officer (GlobeNewswire)
Jul-03-23 03:59AM	5 hot insider trades & hedge fund hits: Buffett picks up more Occidental shares (Investing.com)
Jun-27-23 06:46AM	Daily Vickers Top Buyers & Sellers for 06/27/2023 (Argus Research)
Jun-22-23 11:13AM	MDXG: KOA Program Discontinued (Zacks Small Cap Research)
Jun-20-23 04:01PM	MIMEDX Announces Strategic Realignment: Increases Focus on Wound & Surgical Business, Expected to Significantly Improve Profitability (GlobeNewswire)
May-25-23 01:29PM	Breakeven On The Horizon For MiMedx Group, Inc. (NASDAQ:MDXG) (Simply Wall St.)
May-03-23 09:22AM	Q1 2023 MiMedx Group Inc Earnings Call (Thomson Reuters StreetEvents) +39.37%
07:21AM	MDXG: 1Q:22 Financial Results (Zacks Small Cap Research)
May-02-23 04:17PM	MiMedx: Q1 Earnings Snapshot (AP Finance)
04:01PM	Loading…
04:01PM	MIMEDX Announces First Quarter 2023 Operating and Financial Results (GlobeNewswire)
Apr-18-23 08:00AM	MIMEDX to Host First Quarter 2023 Operating and Financial Results Conference Call on May 2 (GlobeNewswire)
Apr-13-23 08:29AM	Investors in MiMedx Group (NASDAQ:MDXG) have unfortunately lost 57% over the last five years (Simply Wall St.) +6.05%
Mar-23-23 04:01PM	MIMEDX Announces Chief Financial Officer Transition (GlobeNewswire)
Mar-16-23 08:00AM	MIMEDX Comments on Recent Data Brief Published by Office of Inspector General (GlobeNewswire)
Mar-03-23 11:17AM	MiMedx Group, Inc. (NASDAQ:MDXG) Q4 2022 Earnings Call Transcript (Insider Monkey) +13.04%
05:17AM	MiMedx Group Full Year 2022 Earnings: In Line With Expectations (Simply Wall St.)
Mar-01-23 11:22AM	Institutional investors own a significant stake of 38% in MiMedx Group, Inc. (NASDAQ:MDXG) (Simply Wall St.) -12.99%
10:13AM	Q4 2022 MiMedx Group Inc Earnings Call (Thomson Reuters StreetEvents)
04:21AM	MDXG: 2022 Financial Results (Zacks Small Cap Research)
Feb-28-23 04:01PM	MIMEDX Announces Fourth Quarter and Full Year 2022 Operating and Financial Results (GlobeNewswire)
Feb-15-23 08:00AM	MIMEDX to Host Fourth Quarter and Full Year 2022 Operating and Financial Results Conference Call on February 28 (GlobeNewswire)
Jan-31-23 05:38AM	MDXG: Navigating to New Heights: MiMedx Appoints CEO (Zacks Small Cap Research)
Jan-30-23 08:00AM	MIMEDX Appoints Joseph H. Capper as Chief Executive Officer and Director (GlobeNewswire)
Jan-09-23 08:02AM	MIMEDX Confirms Fourth Quarter and Full Year 2022 Net Sales Expectations, Comments on Evolving Medicare Reimbursement Landscape and Provides Corporate Updates (GlobeNewswire)
Jan-04-23 04:01PM	MIMEDX Announces Commercial Launch of EPIFIX® in Japan with Exclusive Distribution Agreement with GUNZE MEDICAL LIMITED (GlobeNewswire)
Jan-03-23 08:00AM	MIMEDX Appoints Ricci S. Whitlow as Chief Operating Officer (GlobeNewswire) +6.83%
Dec-08-22 08:00AM	MIMEDX Announces Wound & Surgical Product Pipeline Expansion via In-Licensing and Distribution Agreement with Turn Therapeutics (GlobeNewswire)
Nov-10-22 08:00AM	MIMEDX to Present at Upcoming Investor Conferences (GlobeNewswire) +10.69%
Nov-03-22 06:32AM	MDXG: KOA Trial Launch Around the Corner (Zacks Small Cap Research) +5.43%
Nov-02-22 04:15PM	MIMEDX Announces Third Quarter 2022 Operating and Financial Results (GlobeNewswire) -8.61%
08:03AM	The past five years for MiMedx Group (NASDAQ:MDXG) investors has not been profitable (Simply Wall St.)
Oct-19-22 08:00AM	MIMEDX to Host Third Quarter 2022 Operating and Financial Results Conference Call on November 2 (GlobeNewswire)
Oct-04-22 08:00AM	MIMEDX Appoints Matt Notarianni as Head of Investor Relations (GlobeNewswire)
Sep-23-22 11:18AM	MDXG: New Product Launches (Zacks Small Cap Research)
Sep-22-22 10:10AM	Institutions along with individual investors who hold considerable shares inMiMedx Group, Inc. (NASDAQ:MDXG) come under pressure; lose 14% of holdings value (Simply Wall St.)
Sep-20-22 08:00AM	MIMEDX Announces Launch of AXIOFILL (GlobeNewswire) -5.25%
Sep-19-22 07:00AM	MIMEDX Announces Launch of AMNIOEFFECT (GlobeNewswire)
Sep-12-22 04:30PM	MIMEDX EPIFIX® Receives Reimbursement Approval in Japan (GlobeNewswire)
12:59PM	MIMEDX, public regenerative medicine company, joins the RegenMed Hubs Innovation Accelerator in Winston-Salem (American City Business Journals)
05:13AM	MDXG: New Captain on the Bridge (Zacks Small Cap Research)
Sep-06-22 07:00AM	MIMEDX Announces Leadership Transition (GlobeNewswire)
Aug-26-22 09:00AM	Regenerative Engineering Society Establishes Award in Honor of MIMEDX Board Member, Dr. Cato T. Laurencin (GlobeNewswire)
Aug-04-22 04:07PM	MIMEDX to Present at the Canaccord Genuity 42nd Annual Growth Conference (GlobeNewswire)
05:30AM	MDXG: 2Q:22 Financial and Operational Results (Zacks Small Cap Research)
Aug-02-22 04:05PM	MIMEDX Announces Second Quarter 2022 Operating and Financial Results (GlobeNewswire)
Jul-27-22 08:00AM	MIMEDX Announces Formation of Regenerative Medicine Scientific Advisory Board Comprised of Renowned Industry and Academic Experts (GlobeNewswire)
Jul-24-22 10:38AM	Is MiMedx Group (NASDAQ:MDXG) Using Too Much Debt? (Simply Wall St.)
Jul-20-22 08:00AM	MIMEDX to Host Second Quarter 2022 Operating and Financial Results Conference Call on August 3 (GlobeNewswire)
Jul-18-22 09:35AM	MIMEDX Welcomes Kate Surdez as Chief Human Resources Officer (GlobeNewswire)
Jun-15-22 08:30AM	MIMEDX Engages Nordic Bioscience Clinical Development A/S to Propel Registrational Trials of Placental Biologic Injectable for Knee Osteoarthritis (GlobeNewswire) +9.20%
Jun-14-22 05:16PM	Prescience Point Capital Management Says MiMedx Shareholders Have Spoken: Voiced Their Desire For Change (PR Newswire)
Jun-07-22 04:05PM	MIMEDX Shareholders Vote to Approve All Proposals at the 2022 Annual Meeting (GlobeNewswire)
02:42PM	Prescience Point Capital Management Calls On MiMedx Group to Immediately Release Preliminary Voting Results of its Annual Meeting (PR Newswire)
Jun-03-22 08:00AM	MIMEDX Reminds Shareholders to Pre-Register for the Upcoming Virtual 2022 Annual Meeting of Shareholders (GlobeNewswire)
Jun-02-22 08:03AM	MIMEDX Addresses Presentation by Prescience Point (GlobeNewswire)
May-31-22 04:05PM	MIMEDX Board Chair Dr. M. Kathleen Behrens Writes Letter to Fellow Shareholders (GlobeNewswire)
02:05PM	Prescience Point Capital Management Releases Presentation Detailing Board And Management Failures at MiMedx Group (PR Newswire)
08:00AM	MIMEDX Receives $4.6 Million Award from the Department of Defense to Advance the Treatment of Combat Casualty Wounds and Burns (GlobeNewswire)
May-25-22 05:26PM	Leading Independent Proxy Advisory Firm ISS Recommends that MIMEDX Shareholders Vote FOR ALL of the Companys Proposals (GlobeNewswire)
May-20-22 09:00AM	Leading Independent Proxy Advisory Firm Glass Lewis Recommends that MIMEDX Shareholders Vote FOR ALL of the Companys Proposals (GlobeNewswire)
May-18-22 04:18PM	MIMEDX Investor Presentation Highlights Clear Strategy for Value Creation (GlobeNewswire) -7.61%
08:55AM	Prescience Point Capital Management Calls on MiMedx to Confirm the Company Has Received Letters of Serious Concern from other Shareholders (PR Newswire)
May-16-22 08:00AM	MIMEDX Mails Letter to Shareholders (GlobeNewswire)
07:55AM	Shareholders in MiMedx Group (NASDAQ:MDXG) are in the red if they invested five years ago (Simply Wall St.)
May-09-22 08:00AM	MIMEDX Comments on Prescience Points False and Misleading Statements (GlobeNewswire) -5.56%
May-06-22 05:30PM	MiMedx Group and Inozyme Stock See Action From Activist Investors (Barrons.com) -7.93%
09:12AM	Prescience Point Capital Management Issues Open Letter to Shareholders of MiMedx Group (PR Newswire)
May-05-22 08:35AM	MDXG: 1Q:22 Financial and Operational Results (Zacks Small Cap Research) -10.93%
08:00AM	MIMEDX to Participate at Upcoming Investor Conferences (GlobeNewswire)
May-03-22 04:32PM	MIMEDX Announces First Quarter 2022 Operating and Financial Results (GlobeNewswire)
Apr-29-22 09:09AM	MIMEDX Comments on Prescience Points Recent Filing (GlobeNewswire)
Apr-20-22 08:00AM	MIMEDX to Host First Quarter 2022 Operating and Financial Results Conference Call on May 4 (GlobeNewswire)
Apr-15-22 09:38AM	Do Insiders Own Lots Of Shares In MiMedx Group, Inc. (NASDAQ:MDXG)? (Simply Wall St.)
Apr-13-22 10:01PM	Analysts Say These 3 Stocks Are Their Top Picks for 2022 (TipRanks) -6.20%
Apr-05-22 08:00AM	MIMEDX to Present Health Economics Clinical Data for EPIFIX® in Treatment of Lower Extremity Diabetic Ulcers at SAWC Spring (GlobeNewswire) -5.20%
Mar-16-22 08:05AM	WoundGenex Partners with MIMEDX to Launch Premier Graft Program to Wound Care Providers Nationwide (PR Newswire) +6.31%
Mar-15-22 08:00AM	MIMEDX to Present at the Canaccord Genuity Musculoskeletal Conference (GlobeNewswire)
Mar-01-22 06:47AM	MDXG: 2021 Results (Zacks Small Cap Research)
Feb-28-22 04:06PM	MIMEDX Announces Fourth Quarter and Full Year 2021 Operating and Financial Results (GlobeNewswire)

MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DOUG RICE	Chief Financial Officer	Nov 21	Buy	7.16	5,000	35,786	102,200	Nov 22 05:01 PM
Stein Robert Benjamin	President, Regenerative Med.	May 16	Sale	5.95	10,365	61,627	317,803	May 17 06:26 PM
Stein Robert Benjamin	President, Regenerative Med.	May 15	Sale	6.15	3,607	22,170	328,168	May 17 06:26 PM
Carlson Peter M	Chief Financial Officer	May 10	Sale	5.93	5,976	35,414	656,435	May 12 06:50 PM
Hulse William Frank IV	General Counsel and CAO	May 10	Sale	5.93	5,870	34,786	456,564	May 12 06:58 PM
Stein Robert Benjamin	President, Regenerative Med.	May 10	Sale	5.93	5,869	34,780	331,775	May 12 06:56 PM
Phelan William Lawrence	Chief Accounting Officer	May 10	Sale	5.93	1,595	9,452	184,219	May 12 06:53 PM
Stein Robert Benjamin	President, Regenerative Med.	May 04	Sale	5.34	51,756	276,470	337,644	May 09 08:32 AM
Phelan William Lawrence	Chief Accounting Officer	May 02	Sale	3.80	5,200	19,739	185,814	May 03 06:26 PM
Carlson Peter M	Chief Financial Officer	Apr 25	Sale	3.74	6,094	22,816	662,411	Apr 27 07:21 PM
Hulse William Frank IV	General Counsel and CAO	Apr 25	Sale	3.74	5,988	22,419	462,434	Apr 27 07:23 PM
Stein Robert Benjamin	President, Regenerative Med.	Apr 25	Sale	3.74	5,987	22,415	389,400	Apr 27 07:24 PM
Phelan William Lawrence	Chief Accounting Officer	Apr 25	Sale	3.74	1,628	6,095	191,014	Apr 27 07:25 PM
Carlson Peter M	Chief Financial Officer	Apr 11	Sale	3.31	6,100	20,191	668,505	Apr 13 05:37 PM
Stein Robert Benjamin	President, Regenerative Med.	Apr 11	Sale	3.31	5,996	19,847	395,387	Apr 13 05:50 PM
Hulse William Frank IV	General Counsel and CAO	Apr 11	Sale	3.31	5,995	19,843	468,422	Apr 13 05:39 PM
Phelan William Lawrence	Chief Accounting Officer	Apr 11	Sale	3.31	1,632	5,402	192,642	Apr 13 05:52 PM
Stein Robert Benjamin	President, Regenerative Med.	Mar 07	Sale	4.24	12,355	52,442	266,318	Mar 09 05:43 PM
Carlson Peter M	Chief Financial Officer	Mar 07	Sale	4.24	12,056	51,173	534,150	Mar 09 05:41 PM
Hulse William Frank IV	General Counsel and CAO	Mar 07	Sale	4.24	11,308	47,998	338,053	Mar 09 05:40 PM
Phelan William Lawrence	Chief Accounting Officer	Mar 07	Sale	4.24	3,396	14,415	141,244	Mar 09 05:42 PM
Carlson Peter M	Chief Financial Officer	Feb 23	Sale	4.50	19,000	85,416	546,206	Feb 24 05:41 PM
Hulse William Frank IV	General Counsel and CAO	Feb 23	Sale	4.53	15,555	70,477	349,361	Feb 24 05:36 PM
Carlson Peter M	Chief Financial Officer	Dec 22	Sale	2.82	4,992	14,053	565,206	Dec 27 07:55 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MDXG

Mimedx Group Inc

Upgrade your FINVIZ experience